Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients



Status:Completed
Conditions:Post-Surgical Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:18 - Any
Updated:10/28/2017
Start Date:August 2013
End Date:September 2014

Use our guide to learn which trials are right for you!

Systemic Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients: A Randomized, Placebo-Controlled Pilot Study

The primary objective is to assess the feasibility and safety of administering continuous
intraoperative lidocaine infusions in adult patients undergoing laparoscopic Roux en Y
Gastric Bypass (RYGB). The secondary objective is to determine if lidocaine administration
versus placebo (dextrose administration) (initiated at the time of anesthesia induction and
continued until extubation) will reduce postoperative narcotic requirements.


Inclusion Criteria:

- Adult patients between the ages of 18-65 years old

- BMI ≥ 40 kg/m2, ≤ 60 kg/m2

- Undergoing a primary laparoscopic RYGB by Dr. Murr

- Agree to be followed 24 hours postoperatively

- Normal K+ and Mg++ serum levels

Exclusion Criteria:

- BMI less than 40 kg/m2, > 60 kg/m2

- Laparoscopic RYGB surgery performed by a surgeon other than Dr. Murr

- Allergy to lidocaine

- Allergy to hydromorphone or ketorolac

- Allergy to corn or amide anesthetics

- Use of (thioridizine)

- Pregnancy

- Abnormalities of ALT or AST

- Intra-operative diagnosis of cirrhosis or portal hypertension

- Intraoperative complications per surgeon

- Intraoperative extensive adhesions per surgeon

- Chronic pain syndrome and chronic use of narcotics

- Severe back pain secondary to degenerative joint disease
We found this trial at
1
site
1 Tampa General Cir
Tampa, Florida 33606
(813) 844-7000
Principal Investigator: Enrico Camporesi, MD
Phone: 813-844-4413
Tampa General Hospital In a diverse city known for its rich culture and beautiful beaches,...
?
mi
from
Tampa, FL
Click here to add this to my saved trials